Intravenous immunoglobulin for post-polio syndrome: a randomised controlled trial. (Q48499866)

12 February 2018

title

Intravenous immunoglobulin for post-polio syndrome: a randomised controlled trial. (English)

1 reference

12 February 2018

1 reference

Georgios Kaponides

4

0 references

Katharina Sunnerhagen

object named as

Katharina Stibrant Sunnerhagen

2

0 references

author name string

Henrik Gonzalez

1

1 reference

12 February 2018

Inger Sjöberg

3

1 reference

12 February 2018

Tomas Olsson

5

1 reference

12 February 2018

Kristian Borg

6

1 reference

12 February 2018

publication date

1 June 2006

1 reference

12 February 2018

published in

Lancet Neurology

1 reference

12 February 2018

volume

5

1 reference

12 February 2018

issue

6

1 reference

12 February 2018

page(s)

493-500

1 reference

12 February 2018

Early and late losses of motor units after poliomyelitis.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970447-1

7 January 2021

An 8-year longitudinal study of muscle strength, muscle fiber size, and dynamic electromyogram in individuals with late polio

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970447-1

7 January 2021

Prior poliomyelitis-evidence of cytokine production in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970447-1

7 January 2021

Prior poliomyelitis-IVIg treatment reduces proinflammatory cytokine production.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970447-1

7 January 2021

Post-polio syndrome spinal cord pathology. Case report with immunopathology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970447-1

7 January 2021

Progressive nemaline (rod) myopathy associated with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970447-1

7 January 2021

Morphologic changes in the muscles of patients with postpoliomyelitis neuromuscular symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970447-1

7 January 2021

Cytokine-induced enhancement of autoimmune inflammation in the brain and spinal cord: implications for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970447-1

7 January 2021

Pyridostigmine in postpolio syndrome: no decline in fatigue and limited functional improvement

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970447-1

7 January 2021

Effect of intravenous immunoglobulin in patients with post-polio syndrome -- an uncontrolled pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970447-1

7 January 2021

National rehabilitation hospital limb classification for exercise, research, and clinical trials in post-polio patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970447-1

7 January 2021

A comparative review of generic quality-of-life instruments

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970447-1

7 January 2021

A comparison of the SF-36 and Nottingham Health Profile in patients with chronic neuropathic pain.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970447-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970447-1

7 January 2021

Age- and gender-related test performance in community-dwelling elderly people: Six-Minute Walk Test, Berg Balance Scale, Timed Up & Go Test, and gait speeds

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970447-1

7 January 2021

Psychometric comparisons of the timed up and go, one-leg stand, functional reach, and Tinetti balance measures in community-dwelling older people.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970447-1

7 January 2021

The physical activity scale for the elderly (PASE): evidence for validity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970447-1

7 January 2021

A comparison of pain measurement characteristics of mechanical visual analogue and simple numerical rating scales.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970447-1

7 January 2021

The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970447-1

7 January 2021

Gabapentin in the prophylaxis of chronic daily headache: a randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970447-1

7 January 2021

The Swedish SF-36 Health Survey III. Evaluation of criterion-based validity: results from normative population.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970447-1

7 January 2021

A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970447-1

7 January 2021

The course of functional status and muscle strength in patients with late-onset sequelae of poliomyelitis: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970447-1

7 January 2021

Pathogenetic mechanisms of post-polio syndrome: morphological, electrophysiological, virological, and immunological correlations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970447-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970447-1

1 reference

7 January 2021

A double-blind, placebo-controlled trial of high-dose prednisone for the treatment of post-poliomyelitis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970447-1

7 January 2021

Administration of recombinant human leukocyte alpha 2-interferon in patients with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970447-1

7 January 2021

Neuropathogenic actions of cytokines assessed in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970447-1

7 January 2021

Autoimmune encephalomyelitis ameliorated by AMPA antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970447-1

7 January 2021

An approach to understanding the mechanisms of poliovirus persistence in infected cells of neural or non-neural origin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970447-1

7 January 2021

The post-polio syndrome as an evolved clinical entity. Definition and clinical description

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970447-1

7 January 2021

Postpolio syndrome: poliovirus persistence is involved in the pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970447-1

7 January 2021

The postpolio syndrome: no evidence for poliovirus persistence

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970447-1

7 January 2021

Antibody titer to the poliovirus in blood and cerebrospinal fluid of patients with post-polio syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970447-1

7 January 2021

10.1016/S1474-4422(06)70447-1

Identifiers

DOI

1 reference

12 February 2018

release_yxxoaeqgfnfapincotwfon6cdy

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yxxoaeqgfnfapincotwfon6cdy

24 November 2022

mapped directly with Wikidata item

PubMed ID

16713921

1 reference

12 February 2018